News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Doc Claims SummerStreet's Amarin Corporation PLC (AMRN) Report is Inaccurate


5/29/2013 7:43:03 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A doctor mentioned in a bearish research note on Amarin (AMRN_) published Tuesday by SummerStreet Research Partners says he was misquoted and did not tell an audience of primary care doctors that FDA wouldn't approve the company's prescription-grade fish oil Vascepa without further clinical data. Dr. Eliot Brinton, reached by phone in Salt Lake City where he practices medicine, confirmed he is the "Amarin insider" mentioned in the Summer Street report. The report, however, was inaccurate, he says.

Help employers find you! Check out all the jobs and post your resume.

Read at The Street.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES